Jingyi Liu1,2,3, Chao Liu3, Jinfeng Zhang4, Yunming Zhang3, Keyin Liu2, Ju‐Xian Song1, Sravan Gopalkrishnashetty Sreenivasmurthy1, Ziying Wang1, Yesi Shi3, Chengchao Chu3, Yang Zhang3, Caisheng Wu5,6, Xianhua Deng2, Xingyang Liu2, Jing Song5,6, Rongqiang Zhuang3, Shuqiong Huang2, Pengfei Zhang3, Min Li1, Lei Wen7,2, Yun‐wu Zhang7,2, Gang Liu7,3
1Mr. & Mrs. Ko Chi-Ming Centre for Parkinson's Disease Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China
2School of Medicine, Xiamen University, Xiamen, 361102, China
3State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China
4Key Laboratory of Molecular Medicine and Biotherapy, School of Life Sciences, Beijing Institute of Technology, Beijing 100081, China
5Laboratory Animal Center, Xiamen University, Xiamen 361102, China
6School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China
7Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, Xiamen University, Xiamen 361102, China